Entity
biotech Description
Value proposition
PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers.
These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families
Pepkon - Innovative peptides to treat cancer
Pepkon is a French preclinical biotechnology company focused on the development of peptide therapies to treat poor prognosis cancers.
https://www.pepkon.fr/
Corporate interactions BETA
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Aster Capital Startup accelerator & VC, Venture Capital and Private Equity Principals | Aster Capital Startup accelerator & VC, Venture Capital and Private Equity Principals | Other | ||
 La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | Other 12 Jul 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 18 Jan 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 5 Jul 2023 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 22 Jun 2023 | | |
 Agoranov Startup accelerator & VC, Technology, Information and Internet | Agoranov Startup accelerator & VC, Technology, Information and Internet | Other 13 Mar 2024 | | |
Similar entities
Loading...
Last news Show all articles
Loading...
Social network dynamics